<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?>

<feed xmlns="http://purl.org/atom/ns#" version="0.3" xml:lang="en-US">
<link href="https://www.blogger.com/atom/19229670" rel="service.post" title="Hepatitis C Therapy" type="application/atom+xml"/>
<link href="https://www.blogger.com/atom/19229670" rel="service.feed" title="Hepatitis C Therapy" type="application/atom+xml"/>
<title mode="escaped" type="text/html">Hepatitis C Therapy</title>
<tagline mode="escaped" type="text/html">Hepatitis C Therapy Information</tagline>
<link href="http://www.about-hepatitis-c.com/hepatitis-c-therapy" rel="alternate" title="Hepatitis C Therapy" type="text/html"/>
<id>tag:blogger.com,1999:blog-19229670</id>
<modified>2006-04-12T22:41:54Z</modified>
<generator url="http://www.blogger.com/" version="6.72">Blogger</generator>
<info mode="xml" type="text/html">
<div xmlns="http://www.w3.org/1999/xhtml">This is an Atom formatted XML site feed. It is intended to be viewed in a Newsreader or syndicated to another site. Please visit the <a href="http://help.blogger.com/bin/answer.py?answer=697">Blogger Help</a> for more info.</div>
</info>
<convertLineBreaks xmlns="http://www.blogger.com/atom/ns#">true</convertLineBreaks>
<entry xmlns="http://purl.org/atom/ns#">
<link href="https://www.blogger.com/atom/19229670/114488171377924137" rel="service.edit" title="Hepatitis C Therapy - A Medical Mystery    Gangrene and Cutaneous Nodules  " type="application/atom+xml"/>
<author>
<name>Greg</name>
</author>
<issued>2006-04-12T11:40:12-07:00</issued>
<modified>2006-04-12T22:41:54Z</modified>
<created>2006-04-12T22:41:53Z</created>
<link href="http://www.about-hepatitis-c.com/hepatitis-c-therapy/2006/04/hepatitis-c-therapy-medical-mystery.html" rel="alternate" title="Hepatitis C Therapy - A Medical Mystery    Gangrene and Cutaneous Nodules  " type="text/html"/>
<id>tag:blogger.com,1999:blog-19229670.post-114488171377924137</id>
<title mode="escaped" type="text/html">Hepatitis C Therapy - A Medical Mystery    Gangrene and Cutaneous Nodules  </title>
<content type="application/xhtml+xml" xml:base="http://www.about-hepatitis-c.com/hepatitis-c-therapy" xml:space="preserve">
<div xmlns="http://www.w3.org/1999/xhtml">
<div xmlns="http://purl.org/atom/ns#"> <br/>
<a href="http://content.nejm.org/cgi/content/full/354/14/1515" rel="nofollow" target="_blank">A Medical Mystery    Gangrene and Cutaneous Nodules</a>
<br/>New England Journal of Medicine -    A 62-year-old man presented with a one-month history of digital gangrene affecting the right hand (Panel A). One digit had been partially amputated 20 years before, after an accident. The skin of his arms and legs had reddish-blue, mottled   <br/>
<br/>
<a href="http://www.dailytimes.com.pk/default.asp?page=2006\03\31\story_31-3-2006_pg7_18" rel="nofollow" target="_blank">   Hepatitis C can cause liver cancer   </a>
<br/>Daily Times - LAHORE: Hepatitis C can lead to liver cancer and liver failure if not diagnosed and treated at an early stage, said Prof Dr Arif Qayyum Khan, president of the Pakistan Association for Study of Liver Diseases, on Liver Day on Thursday. Dr Arif said   <br/>
<br/>
<a href="http://www.thestreet.com/_tsclsii/stocks/pharmaceuticals/10277576.html" rel="nofollow" target="_blank">Hepatitis Still a Frustrating Foe</a>
<br/>Street.Com - Since March 14, three drugmakers, Human Genome Sciences ( HGSI :Nasdaq - news - research - Cramer's Take ), Idenix Pharmaceuticals ( IDIX :Nasdaq - news - research - Cramer's Take ) and Valeant Pharmaceuticals ( VRX :NYSE - news - research - Cramer's   <br/>
<br/>
<a href="http://www.investors.com/editorial/IBDArticles.asp?artsec=22&amp;issue=20060331" rel="nofollow" target="_blank">Hepatitis C Market: Plenty Of Potential, But Little Progress</a>
<br/>Investors Business Daily - The month of March was not kind to a pair of companies racing to find a cure or vaccine for hepatitis C, the often fatal liver disease that's been called a global epidemic by the World Health Organization. On March 21, Valeant Pharmaceuticals ( VRX   <br/>
<br/>
<a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=40915" rel="nofollow" target="_blank">Relative Risks Of Cirrhosis From Non-alcoholic Steatohepatitis</a>
<br/>Medical News Today - Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events. These findings are   <br/>
<br/>
<a href="http://www.modbee.com/life/healthyliving/story/12041541p-12797995c.html" rel="nofollow" target="_blank">Support Groups: Health</a>
<br/>Modesto Bee - ALZHEIMER'S SUPPORT GROUPS: Alzheimer's Affiliates: Meets from 9:30 to 11 a.m. the third Tuesday of each month at Sylvan Improvement Club, 2545 Sylvan Ave., Modesto, 521-1606. Miller's Place: Meets at 6:30 p.m. the second and fourth Wednesdays and at   <br/> </div>
</div>
</content>
<draft xmlns="http://purl.org/atom-blog/ns#">false</draft>
</entry>
</feed>

